Cargando…
Vagus Nerve Stimulation: A Potential Adjunct Therapy for COVID-19
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) through excessive end organ inflammation. Despite improved understanding of the pathophysiology, management, and the great efforts worldwide to produce effective drugs, death rates of CO...
Autores principales: | Azabou, Eric, Bao, Guillaume, Bounab, Rania, Heming, Nicholas, Annane, Djillali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137825/ https://www.ncbi.nlm.nih.gov/pubmed/34026778 http://dx.doi.org/10.3389/fmed.2021.625836 |
Ejemplares similares
-
Randomized Controlled Study Evaluating Efficiency of Low Intensity Transcranial Direct Current Stimulation (tDCS) for Dyspnea Relief in Mechanically Ventilated COVID-19 Patients in ICU: The tDCS-DYSP-COVID Protocol
por: Azabou, Eric, et al.
Publicado: (2020) -
Vasopressor Therapy and the Brain: Dark Side of the Moon
por: Heming, Nicholas, et al.
Publicado: (2020) -
Immune Effects of Corticosteroids in Sepsis
por: Heming, Nicholas, et al.
Publicado: (2018) -
Thiamine status and lactate concentration in sepsis: A prospective observational study
por: Heming, Nicholas, et al.
Publicado: (2020) -
Vagus nerve stimulation: An evolving adjunctive treatment for cardiac disease
por: Akdemir, Barış, et al.
Publicado: (2016)